SKIN CHALLENGES IN COVID-19 PANDEMIC: THE IMPORTANCE OF COSMECEUTICALS
Abstract
Although COVID-19 is present in a milder form more often, systemic disorders caused by the virus lead to multiple organ malfunctions. Skin manifestations are the consequence of the disease itself, but also the result of preventative measures taken to avoid the infection. They generally do not require pharmacotherapy except in severe cases. Depending on severity of COVID 19 related skin disorder, cosmeceuticals are often recommended in their management. In this study we highlighted skin adverse events related to all aspects of COVID-19 pandemic aiming to provide a comprehensive overview and enlighten the role of cosmeceuticals in the treatment of those skin issues, according to published studies and guidelines.
Different steps were conducted in preparation of this review- identification of all factors that affect skin in pandemics (protective measures, disease itself, post-COVID syndrome), selection and classification of reported skin symptoms which could be managed using cosmeceuticals, according to relevant papers and guidelines.
Skin challenges in COVID-19 pandemics could be divided into three main categories: 1) Cutaneous manifestations of COVID-19 disease; 2) Cutaneous symptoms as a result of wearing protective equipment and using disinfectants and 3) Cutaneous symptoms related to the post COVID-19 syndrome. Cosmeceuticals, a unique category of cosmetic products with therapeutic benefits, are highly recommended in literature for their management, except in severe skin disorders. Since the introduction of cosmeceutical concept, those topicals became extremely important part of dermatologist’s armamentarium. COVID-19 pandemic confirms their importance.
References
REFERENCES
1. Cao X. COVID-19: immunopathology and its implications for therapy. Nature reviews immunology. 2020 May;20(5):269-70.
2. Spick M, Longman K, Frampas C, Lewis H, Costa C, Walters DD, Stewart A, Wilde M, Greener D, Evetts G, Trivedi D, Barran P, Pitt A, Bailey M. Changes to the sebum lipidome upon COVID-19 infection observed via rapid sampling from the skin. EClinicalMedicine. 2021 Mar;33:100786.
3. Searle T, Ali FR, Al-Niaimi F. Identifying and addressing "Maskne" in clinical practice. Dermatol Ther. 2021 Jan;34(1):e14589.
4. Rundle CW, Presley CL, Militello M, Barber C, Powell DL, Jacob SE, Atwater AR, Watsky KL, Yu J, Dunnick CA. Hand hygiene during COVID-19: Recommendations from the American Contact Dermatitis Society. J Am Acad Dermatol. 2020 Dec;83(6):1730-1737.
5. Nabavi N. Long covid: how to define it and how to manage it. BMJ. 2020;370:m3489.
6. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
7. Drenovska K, Schmidt E, Vassileva S. Covid-19 pandemic and the skin. Int J Dermatol. 2020 Nov;59(11):1312-1319.
8. Genovese G, Moltrasio C, Berti E, Marzano AV. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives. Dermatology. 2021;237(1):1-12.
9. Tan SW, Tam YC, Oh CC. Skin manifestations of COVID-19: A worldwide review. JAAD International, 2021 (2): 119-133.
10. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020 May;34(5):e212-e213.
11. Marzano AV, Cassano N, Genovese G, Moltrasio C, Vena GA. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol. 2020 Sep;183(3):431–42.
12. Galván Casas C, Català A, Carretero Hernández G, et al. Classifi cation of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol 2020; 183(1):71–77.
13. Krajewski PK, Maj J, Szepietowski JC. Cutaneous hyperaesthesia in SARS-CoV-2 infection: rare but not unique clinical manifestation. Acta Derm Venereol 2021; 101(1):adv00366.
14. Atzori L, Recalcati S, Ferreli C, Hoenig LJ, Rongioletti F. COVID-19–related skin manifestations: Update on therapy. Clinics in Dermatology 2021; 39 (5)2021: 920-926.
15. Moncrieff G, Van Onselen J, Young T (2015) The role of emollients in maintaining skin integrity. Wounds UK; 11 (1): 68-74.
16. Kim J, Yoo S, Kwon OS, Jeong ET, Lim JM, Park SG. Influence of quarantine mask use on skin characteristics: One of the changes in our life caused by the COVID‐19 pandemic. Skin Research and Technology. 2020 Dec 28.
17. Park SR, Han J, Yeon YM, Kang NY, Kim E. Effect of face mask on skin characteristics changes during the COVID‐19 pandemic. Skin Research and Technology. 2020 Nov 20.
18. Tasic-Kostov M, Martinović M, Ilic D, Cvetkovic M. Cotton versus medical face mask influence on skin characteristics during COVID-19 pandemic: A short-term study. Skin Res Technol. 2022 Jan;28(1):66-70.
19. Teo WL. Diagnostic and management considerations for “maskne” in the era of COVID-19. Journal of the American Academy of Dermatology. 2020 Oct 1.
20. Yan Y, Chen H, Chen L, et al. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019. Dermatologic Therapy. 2020; e13310.
21. Teo WL. Diagnostic and management considerations for "maskne" in the era of COVID-19. J Am Acad Dermatol. 2021 Feb;84(2):520-521.
22. Dréno B, Dagnelie MA, Khammari A, Corvec S. The Skin Microbiome: A New Actor in Inflammatory Acne. Am J Clin Dermatol. 2020 Sep;21(Suppl 1):18-24. doi: 10.1007/s40257-020-00531-1.
24. Wollina U. Challenges of COVID-19 pandemic for dermatology. Dermatol Ther. 2020;33(5):e13430
25. Akl J, El- Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol. 2021;20:3105–3115.
26. Stettler, H.; de Salvo, R.; Brandt, M.; Effertz, A.-K.; Laing, S.; Trapp, S. Performance and Acceptability of a New Dexpanthenol-Containing Hand Cream in Subjects with Sensitive and Very Dry Skin: A Randomized Controlled Study. Cosmetics 2022, 9, 44.
27. https://www.aad.org/public/everyday-care/skin-care-basics/dry/coronavirus-handwashing
28. Diotallevi, F., Mazzanti, S., Properzi, P., Olivieri, S., Giacometti, A. and Offidani, A. (2022), Is there a POST-COVID dermatological syndrome? The integrated dermato-infectious disease experience of a single centre. J Eur Acad Dermatol Venereol, 36: e166-e169.
29. Müller-Ramos, P., Ianhez, M., Silva de Castro, C.C., Talhari, C., Criado, P.R. and Amante Miot, H. (2022), Post-COVID-19 hair loss: prevalence and associated factors among 5,891 patients. Int J Dermatol, 61: e162-e164
30. McMahon DE, Gallman AE, Hruza GJ, Rosenbach M, Lipoff JB, Desai SR, French LE, Lim H, Cyster JG, Fox LP, Fassett MS, Freeman EE. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021 Mar;21(3):313-314.
31. Rogers, N.E. (2013). Cosmeceuticals for Hair Loss and Hair Care. In Cosmeceuticals and Cosmetic Practice, P.K. Farris (Ed.).